alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
§ 417.592 Additional benefits requirement. ( a ) *General rules.* ( 1 ) An HMO or CMP that has an APCRP (as determined under § 417.590) greater than its ACR (as determined under § 417.594) must elect one of the options specified in paragraph (b) of this section.
( 2 ) The dollar value of the elected option must, over the course of a contract period, be at least equal to the difference between the APCRP and the proposed ACR.
( b ) *Options* — ( 1 ) *Additional benefits.* Provide its Medicare enrollees with additional benefits in accordance with paragraph (c) of this section.
( 2 ) *Payment reduction.* Request CMS to reduce its monthly payments.
( 3 ) *Combination of additional benefits and payment reduction.* Provide fewer than the additional benefits required under paragraph (b)(1) of this section and request CMS to reduce the monthly payments by the remaining difference between the APCRP and the ACR.
( 4 ) *Combination of additional benefits and withholding in a stabilization fund.* Provide fewer than the additional benefits required under paragraph (b)(1) of this section, and request CMS to withhold in a stabilization fund (as provided in § 417.596) the remaining difference between the APCRP and the ACR.
( c ) *Special rules: Additional benefits option.* ( 1 ) The HMO or CMP must determine additional benefits separately for enrollees entitled to both Part A and Part B benefits and those entitled only to Part B.
( 2 ) The HMO or CMP may elect to provide additional benefits in any of the following forms— ( i ) A reduction in the HMO's or CMP's premium or in other charges it imposes in the form of deductibles or coinsurance.
( ii ) Health benefits in addition to the required Part A and Part B covered services.
( iii ) A combination of reduced charges and additional benefits.
( d ) *Notification to CMS.* ( 1 ) The HMO or CMP must give CMS notice of its ACR and its weighted APCRP at least 45 days before its contract period begins.
( 2 ) An HMO or CMP that elects the option of providing additional benefits must include in its submittal— ( i ) A description of the additional benefits it will provide to its Medicare enrollees; and
( ii ) Supporting evidence to show that the selected benefits meet the requirements of paragraph (a)(2) of this section with respect to dollar value equivalence.
[60 FR 46232, Sept. 6, 1995]
Editorial Note on Part 84
Editorial Note: Nomenclature changes to part 84 appear at 69 FR 18803, Apr. 9, 2004.

§ 84.309 Additional testing and requirements for dockable CCERs. ( a ) NIOSH will conduct additional testing of the CCERs that are designed to allow the user to resupply the oxygen source and the carbon dioxide scrubber while using the respirator during an escape. ( 1 ) NIOSH will test the docking mechanism and procedure to ensure that they maintain the integrity of the breathing circuit (against the intake of hazardous fumes or gases) and the continuity of the breathing gas supply throughout the docking process.
( 2 ) NIOSH will test the docking mechanism and procedure to ensure that users can employ the docking process reliably, safely, and quickly under escape conditions.
( b ) NIOSH will designate CCERs that pass the tests specified in this section as “Dockable.”
( c ) NIOSH will assign the capacity rating to the dockable CCER, as specified under § 84.304(d), by conducting the capacity testing using only the breathing gas supply included for the initial use of the wearable apparatus.
( d ) NIOSH will test the supplemental capacities of all breathing gas resupply units produced by the manufacturer for use with the dockable CCER. Such tests will follow procedures consistent with those specified under § 84.304, including the rating requirements in § 84.304(d). The manufacturer must label the breathing gas resupply unit to indicate its capacity as tested by NIOSH and its compatibility with the CCER for which it is designed.
( e ) NIOSH may require the applicant to provide additional units of the CCER and breathing gas resupply units to conduct the testing specified in this section.
( f ) NIOSH will not approve a CCER with docking components, with or without the “Dockable” NIOSH designation, unless it satisfies the testing and other requirements of this section.
Home2022 Certificates of Competency for Nominees to be Chiefs of Mission...Ratney, Michael Alan – Kingdom of Saudi Arabia – April 2022

# 									Ratney, Michael Alan – Kingdom of Saudi Arabia – April 2022							

Certificate of Competency

April 29, 2022

REPORT FOR THE COMMITTEE ON FOREIGN RELATIONS

UNITED STATES SENATE

SUBJECT: Ambassadorial Nomination: Certificate of Demonstrated Competence — Foreign Service Act, Section 304(a)(4)

POST: Kingdom of Saudi Arabia

CANDIDATE: Michael Alan Ratney

Michael Alan Ratney, a career member of the Senior Foreign Service with the rank of Minister-Counselor, currently serves as Acting Deputy Director at the Department of State’s Foreign Service Institute. Previously, he served as Chargé d’Affaires a.i. at the U.S. Embassy in Jerusalem and was the Dean of the School of Language Studies at the Foreign Service Institute. Prior to that, Ratney was on the faculty of the National Defense University. He served as the State Department’s acting Deputy Assistant Secretary for the Levant and Israel and Palestinian Affairs and was the U.S. Special Envoy for Syria. Earlier, Ratney was the U.S. Consul General in Jerusalem. He was Deputy Assistant Secretary for International Media in the State Department’s Bureau of Public Affairs. Prior to that, he served as Spokesman for the State Department’s Bureau of Near Eastern Affairs. Other assignments include Deputy Chief of Mission at the U.S. Embassy in Doha, Qatar, as well as tours in Mexico City, Baghdad, Beirut, Casablanca, Bridgetown, and Washington, DC. Ratney’s deep and substantive background in Near Eastern affairs, proficiency in Arabic, demonstrated ability to lead large interagency teams, and extensive expertise in press and public diplomacy, all make him a well-qualified candidate for Ambassador to the Kingdom of Saudi Arabia.

Mr. Ratney earned a BS from Boston University, and an MA from the George Washington University. He is the recipient of multiple State Department performance awards, including six Senior Foreign Service Performance awards and a Presidential Meritorious Service award, and speaks Arabic and French.

Back to Top
WORKING WITH RUSSIAN BUSINESSPARTNERS

----
Exhibit 31(b)
 CERTIFICATION PURSUANT TO RULE 13a-14(a) and 15d-14(a)
  1.
    
    I have reviewed this report on Form 10-Q of Interphase Corporation (the Company);2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material fact
or omit to state a material fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading with respect to the period
covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information included in
this report, fairly present in all material respects the financial condition, results of
operations and cash flows of the Company as of, and for, the periods presented in this report;4.
    
    The Companys other certifying officer and I are responsible for establishing and maintaining
disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))
and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the Company and have:
     5.
    
    The Companys other certifying officer and I have disclosed, based on our most recent
evaluation of internal control over financial reporting, to the Companys auditors and the
audit committee of the Companys board of directors:
   Date: May 12, 2010
    Signature:
    /s/ Thomas N. Tipton Jr.Chief Financial Officer
Editorial Note on Part 84
Editorial Note: Nomenclature changes to part 84 appear at 69 FR 18803, Apr. 9, 2004.

§ 84.206 Particulate tests; respirators with filters; minimum requirements; general. ( a ) Three respirators with cartridges containing, or having attached to them, filters for protection against particulates will be tested in accordance with the provisions of § 84.207.
( b ) In addition to the test requirements set forth in paragraph (a) of this section, three such respirators will be tested, as appropriate, in accordance with the provisions of §§ 84.170 through 84.181; however, the maximum allowable resistance of complete particulate, and gas, vapor, or gas and vapor chemical cartridge respirators shall not exceed the maximum allowable limits set forth in § 84.203.
[60 FR 30355, June 8, 1995, as amended at 85 FR 20607, Apr. 14, 2020]
# C_2005295EN.01002001.xml

| 26.11.2005 | EN | Official Journal of the European Union | C 295/20 |
| --- | --- | --- | --- |

26.11.2005

EN

Official Journal of the European Union

C 295/20

---

Non-opposition to a notified concentration

(Case COMP/M.3999 — Gazprom/Sibneft)

(2005/C 295/12)

(Text with EEA relevance)

On 18 November 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes; |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes;

| — | in electronic form on the EUR-Lex website under document number 32005M3999. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3999. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---
ex10-23.htm


    
      

      

    

     

    EXHIBIT
10.23

    
 

    McDERMOTT
INTERNATIONAL, INC.

    


    Summary
of

    2009
Named Executive Officer

    Base
Salary and Target EICP Compensation

    


    


    


    
      
        	
                Named

                Executive
      Officers

              	
                Base

                Salary

              	
                Target
      Award Opportunity

                (as
      a % of 2009 base salary)

              
	
                John
      A. Fees

                Chief
      Executive Officer, McDermott
      International, Inc.

                 

              	
                $900,000

              	
                 100%

              
	
                Michael
      S. Taff

                Senior
      Vice President & Chief Financial Officer, McDermott International,
      Inc.

                 

              	
                $505,000

              	
                70%

              
	
                Brandon
      C. Bethards

                    President
      & Chief Executive Officer, The
      Babcock & Wilcox Company

                 

              	
                $526,200

              	
                70%

              
	
                Robert
      A. Deason

                    President
      & Chief Executive Officer, J.
      Ray McDermott, S.A.

                 

              	
                $555,000

              	
                70%

              
	
                John
      T. Nesser

                Executive
      Vice President & Chief Operating Officer, J.
      Ray McDermott, S.A.

              	
                $500,000

              	
                70%
HomeOffice of the SpokespersonPress Releases...Renewal of the Charter of the Cultural Property Advisory Committee

# 									Renewal of the Charter of the Cultural Property Advisory Committee							

Media Note

Office of the Spokesperson

June 15, 2022

The U.S. Department of State renewed the Charter of the Cultural Property Advisory Committee.  The Committee was established by the Convention on Cultural Property Implementation Act (Public Law 97-446) to provide recommendations regarding requests for assistance from foreign governments under the UNESCO 1970 *Convention on the Means of Prohibiting and Preventing the Illicit Import, Export and Transfer of Ownership of Cultural Property*.

The Committee carries out investigation and review of foreign government requests and provides recommendations to the State Department regarding agreements or emergency actions that create import restrictions on designated archaeological and/or ethnological material.  The Committee also undertakes continuing review of the effectiveness of cultural property agreements and emergency actions.

The presidentially-appointed members include individuals representing the interests of museums; experts in the fields of archaeology, anthropology, or related areas; experts in the international sale of archaeological, ethnological, and other cultural property; and individuals who represent the interests of the general public.

For further information, contact ECA-Press@state.gov.

Tags

Cultural ObjectsCultural PropertiesOffice of the Spokesperson

Back to Top
<TABLE> <S> <C>

<ARTICLE>                     5
<LEGEND>
     IMTEC, Inc., EX-27, FDS for 10-Q, March 31, 1999
</LEGEND>
<CIK>                         0000730045
<NAME>                        IMTEC, Inc.
<MULTIPLIER>                                   1
<CURRENCY>                                     US
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              JUN-30-1999
<PERIOD-START>                                 JAN-01-1999
<PERIOD-END>                                   MAR-31-1999
<EXCHANGE-RATE>                                1
<CASH>                                         39099
<SECURITIES>                                   0
<RECEIVABLES>                                  2824243
<ALLOWANCES>                                   213000
<INVENTORY>                                    2472717
<CURRENT-ASSETS>                               5292495
<PP&E>                                         8874297
<DEPRECIATION>                                 4864480
<TOTAL-ASSETS>                                 9376117
<CURRENT-LIABILITIES>                          2330964
<BONDS>                                        373403
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<COMMON>                                       15873
<OTHER-SE>                                     2599163
<TOTAL-LIABILITY-AND-EQUITY>                   7045153
<SALES>                                        9949040
<TOTAL-REVENUES>                               9949040
<CGS>                                          5687331
<TOTAL-COSTS>                                  5687331
<OTHER-EXPENSES>                               3197809
<LOSS-PROVISION>                               213353
<INTEREST-EXPENSE>                             55591
<INCOME-PRETAX>                                1011293
<INCOME-TAX>                                   339749
<INCOME-CONTINUING>                            611544
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   611544
<EPS-PRIMARY>                                  0.39
<EPS-DILUTED>                                  0.37
        


</TABLE>
EXHIBIT 32.2


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


         In connection with the quarterly report of QMed, Inc. (the "Company")
on Form 10-Q for the period ending August 31, 2003 as filed with the Securities
and Exchange Commission on October 15, 2003 (the "Report"), I, William T.
Schmitt, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C.
ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002,
that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.



/s/ William T. Schmitt, Jr.
---------------------------------------
William T. Schmitt, Jr.
Senior Vice President, Chief Financial
Officer and Treasurer
October 15, 2003


A signed original of this certification has been provided to the Company and
will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
- PEPFAR Home
- About Us
- Our Priorities
- Where We Work
- Results and Impact
- Partnerships
- Remarks and Releases
- Reports and Guidance

HomeThe United States President’s Emergency Plan for AIDS Relief...New PEPFAR Youth Initiative: $20 Million to Address HIV/AIDS Among Youth

# 									New PEPFAR Youth Initiative: $20 Million to Address HIV/AIDS Among Youth							

PEPFAR Release

February 23, 2024

The U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), led by the State Department’s Bureau of Global Health Security and Diplomacy, announced a new $20 million initiative to strengthen youth-focused HIV programming, center youth HIV leadership, and promote innovation in HIV prevention, case finding, and treatment outcomes in PEPFAR-supported countries. Ambassador Dr. John Nkengasong, U.S. Global AIDS Coordinator and Senior Bureau Official for Global Health Security and Diplomacy, made the announcement about PEPFAR’s Youth Initiative during a hybrid youth special session in Cape Town, South Africa, alongside thousands of youth from around the world.

HIV/AIDS remains a health threat globally and is among the leading causes of death in Africa, which has the fastest growing and youngest population of any continent. Young people are at a high risk for HIV infection and generally have lower rates of being on lifesaving treatment and being virally suppressed relative to adults. Adolescent girls and young women bear a disproportionate burden of new HIV infections among young people, accounting for nearly two out of three new HIV infections among young people globally. In addition to PEPFAR’s ongoing programming to close equity gaps among priority populations, one of the goals of the Youth Initiative is to support innovations for effective HIV awareness, prevention, and treatment strategies that engage youth-led and youth-driven organizations. PEPFAR also aims to strengthen the capacity of youth-led organizations and elevate youth leadership to improve their engagement with country governments, the private sector, and global stakeholders in the HIV/AIDS response.

Young people are catalysts for change and innovation in the fight to end HIV/AIDS as a public health threat by 2030. The United States, through PEPFAR, has saved more than 25 million lives and remains a committed partner in the global effort to increase engagement and amplify the voices of youth in the fight against HIV/AIDS.

The PEPFAR Youth Initiative is subject to availability of appropriated funds and completion of congressional notification procedures.

For media inquiries, please contact GHSD_publicaffairs@state.gov.

Tags

Bureau of African AffairsGlobal HealthHIV/AIDSThe United States President’s Emergency Plan for AIDS Relief

Back to Top
Editorial Note on Part 84
Editorial Note: Nomenclature changes to part 84 appear at 69 FR 18803, Apr. 9, 2004.

§ 84.130 Supplied-air respirators; description. Supplied-air respirators, including all completely assembled respirators designed for use as respiratory protection during entry into and escape from atmospheres not immediately dangerous to life or health are described as follows: ( a ) *Type “A” supplied-air respirators.* A hose mask respirator, for entry into and escape from atmospheres not immediately dangerous to life or health, which consists of a motor-driven or hand-operated blower that permits the free entrance of air when the blower is not operating, a strong large-diameter hose having a low resistance to airflow, a harness to which the hose and the life-line are attached and a tight-fitting facepiece.
( b ) *Type “AE” supplied-air respirators.* A Type “A” supplied-air respirator equipped with additional devices designed to protect the wearer's head and neck against impact and abrasion from rebounding abrasive material, and with shielding material such as plastic, glass, woven wire, sheet metal, or other suitable material to protect the window(s) of facepieces, hoods, and helmets which do not unduly interfere with the wearer's vision and permit easy access to the external surface of such window(s) for cleaning.
( c ) *Type “B” supplied-air respirators.* A hose mask respirator, for entry into and escape from atmospheres not immediately dangerous to life or health, which consists of a strong large-diameter hose with low resistance to airflow through which the user draws inspired air by means of his lungs alone, a harness to which the hose is attached, and a tight-fitting facepiece.
( d ) *Type “BE” supplied-air respirators.* A type “B” supplied-air respirator equipped with additional devices designed to protect the wearer's head and neck against impact and abrasion from rebounding abrasive material, and with shielding material such as plastic, glass, woven wire, sheet metal, or other suitable material to protect the window(s) of facepieces, hoods, and helmets which do not unduly interfere with the wearer's vision and permit easy access to the external surface of such window(s) for cleaning.
( e ) *Type “C” supplied-air respirators.* An airline respirator, for entry into and escape from atmospheres not immediately dangerous to life or health, which consists of a source of respirable breathing air, a hose, a detachable coupling, a control valve, orifice, a demand valve or pressure demand valve, an arrangement for attaching the hose to the wearer, and a facepiece, hood, or helmet.
( f ) *Type “CE” supplied-air respirators.* A type “C” supplied-air respirator equipped with additional devices designed to protect the wearer's head and neck against impact and abrasion from rebounding abrasive material, and with shielding material such as plastic, glass, woven wire, sheet metal, or other suitable material to protect the window(s) of facepieces, hoods, and helmets which do not unduly interfere with the wearer's vision and permit easy access to the external surface of such window(s) for cleaning.
Editorial Note on Part 460
Editorial Note: Nomenclature changes to part 460 appear at 67 FR 61504, Oct. 1, 2002.

§ 460.90 PACE benefits under Medicare and Medicaid. If a Medicare beneficiary or Medicaid beneficiary chooses to enroll in a PACE program, the following conditions apply: ( a ) Medicare and Medicaid benefit limitations and conditions relating to amount, duration, scope of services, deductibles, copayments, coinsurance, or other cost-sharing do not apply.
( b ) The participant, while enrolled in a PACE program, must receive Medicare and Medicaid benefits solely through the PACE organization.